Greek pharma innovation faces bleak future, industry wants ‘urgent changes’ [Advocacy Lab]

Clawbacks, terminated therapies, delays, lay-offs and disinvestment have produced a worrying pharma organization atmosphere in Greece, industry has advised

Source: Euractiv